Seminar: Impact of new regulations on the future of radiopharmacy – KU Leuven

Seminar: Impact of new regulations on the future of radiopharmacy – KU Leuven

November 19, 2022

Register here

Direct Link to enter the Q&A


Recently introduced and upcoming legislation will change the way radiopharmacies and nuclear medicine departments are organised in the future. This is all true in the fields of commercial production of radiopharmaceuticals, clinical studies with in house produced radiopharmaceuticals as well as the daily routine preparations of Tc-99m labelled radiopharmaceuticals.
In this seminar we try to show the future impact of these regulations. More insight will be given not only from a users point of view, but also from the authorities point of view. The FAHMP will be represented by Mr. Jean Guillaume (GMDP inspector) and the users by Prof. Dr. Filip De Vos from the Department of Radiopharmay of the University of Ghent.
The seminar will end with a round table discussion where audience members will have the chance to ask questions to the involved parties. This round table will include a member of most stakeholders: FAHMP, FANC/AFCN, a nuclear medicine physician, a radiopharmacist and a hospital pharmacists.

Program (download here)

09:00-09:20 Welcome + presentation BARR
Guy Bormans ( Radiopharmacist, KULeuven) 
09:20-10:00 Impact of new regulations on radiopharmacy: a FAMHP view
  Jean Guillaume (FAMHP)
10:00-10:40 Impact of new regulations on radiopharmacy: a users view 
10:40-11:15 Coffee break
11:15-12:00 Round table discussion with the point of view of FANC (Marleen Vandecapelle), FAMHP (Jean Guillaume), a hospital pharmacist (to be confirmed) and two nuclear medicine physicians  (Marleen Keyaert and Vanessa Scheflhout)
Moderators: Dominique Vanderghinste (UZA) and Vicky Caveliers (UZBrussel)


Leuven, Herestraat 49, campus Gasthuisberg, Onderwijs & Navorsing 1 building, auditorium GA3.


RIZIV/INAMI1 accreditation requested: answer pending 

FANC/AFCN radiation protection continuing education requested: answer pending

Accreditation for invited hospital pharmacist requested

1 RIZIV/INAMI accreditation for nuclear medicine physicians is available for BELNUC members only.

This event is kindly supported by Cyclomedica Europe.